These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition. Lück M; Pistel KF; Li YX; Blunk T; Müller RH; Kissel T J Control Release; 1998 Nov; 55(2-3):107-20. PubMed ID: 9795026 [TBL] [Abstract][Full Text] [Related]
3. Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of gamma-irradiation on radical formation and polymer degradation. Bittner B; Mäder K; Kroll C; Borchert HH; Kissel T J Control Release; 1999 May; 59(1):23-32. PubMed ID: 10210719 [TBL] [Abstract][Full Text] [Related]
4. Co-effect of aqueous solubility of drugs and glycolide monomer on in vitro release rates from poly(D,L-lactide-co-glycolide) discs and polymer degradation. Kim JM; Seo KS; Jeong YK; Hai BL; Kim YS; Khang G J Biomater Sci Polym Ed; 2005; 16(8):991-1007. PubMed ID: 16128233 [TBL] [Abstract][Full Text] [Related]
5. Sustained release microspheres of metoclopramide using poly(D,L-lactide-co-glycolide) copolymers. Elkheshen SA; Radwan MA J Microencapsul; 2000; 17(4):425-35. PubMed ID: 10898083 [TBL] [Abstract][Full Text] [Related]
6. Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states. Kranz H; Ubrich N; Maincent P; Bodmeier R J Pharm Sci; 2000 Dec; 89(12):1558-66. PubMed ID: 11042603 [TBL] [Abstract][Full Text] [Related]
7. Vancomycin release from poly(D,L-lactide) and poly(lactide-co-glycolide) disks. Ozalp Y; Ozdemir N; Hasirci V J Microencapsul; 2002; 19(1):83-94. PubMed ID: 11811762 [TBL] [Abstract][Full Text] [Related]
8. Controlled delivery of therapeutics from microporous membranes. II. In vitro degradation and release of heparin-loaded poly(D,L-lactide-co-glycolide). Kreitz MR; Domm JA; Mathiowitz E Biomaterials; 1997 Dec; 18(24):1645-51. PubMed ID: 9613812 [TBL] [Abstract][Full Text] [Related]
9. Critical properties of lactide-co-glycolide polymers for the use in microparticle preparation by the aerosol solvent extraction system. Engwicht A; Girreser U; Müller BW Int J Pharm; 1999 Aug; 185(1):61-72. PubMed ID: 10425366 [TBL] [Abstract][Full Text] [Related]
10. Sterilized ibuprofen-loaded poly(D,L-lactide-co-glycolide) microspheres for intra-articular administration: effect of gamma-irradiation and storage. Fernández-Carballido A; Herrero-Vanrell R; Molina-Martínez IT; Pastoriza P J Microencapsul; 2004 Sep; 21(6):653-65. PubMed ID: 15762322 [TBL] [Abstract][Full Text] [Related]
11. Chitin/PLGA blend microspheres as a biodegradable drug-delivery system: phase-separation, degradation and release behavior. Mi FL; Lin YM; Wu YB; Shyu SS; Tsai YH Biomaterials; 2002 Aug; 23(15):3257-67. PubMed ID: 12102197 [TBL] [Abstract][Full Text] [Related]
12. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers. Jackson JK; Hung T; Letchford K; Burt HM Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895 [TBL] [Abstract][Full Text] [Related]
13. Kinetics of a model nucleoside (guanosine) release from biodegradable poly(DL-lactide-co-glycolide) microspheres: a delivery system for long-term intraocular delivery. Chowdhury DK; Mitra AK Pharm Dev Technol; 2000; 5(2):279-85. PubMed ID: 10810757 [TBL] [Abstract][Full Text] [Related]
14. Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems. Schrier JA; DeLuca PP Pharm Dev Technol; 1999; 4(4):611-21. PubMed ID: 10578516 [TBL] [Abstract][Full Text] [Related]
15. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Jain RA Biomaterials; 2000 Dec; 21(23):2475-90. PubMed ID: 11055295 [TBL] [Abstract][Full Text] [Related]
16. Preparation of poly(D,L-lactide) and copoly(lactide-glycolide) microspheres of uniform size. Shiga K; Muramatsu N; Kondo T J Pharm Pharmacol; 1996 Sep; 48(9):891-5. PubMed ID: 8910847 [TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres. Kostanski JW; Thanoo BC; DeLuca PP Pharm Dev Technol; 2000; 5(4):585-96. PubMed ID: 11109259 [TBL] [Abstract][Full Text] [Related]
18. Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition. Park TG Biomaterials; 1995 Oct; 16(15):1123-30. PubMed ID: 8562787 [TBL] [Abstract][Full Text] [Related]
19. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres. Uchida T; Yagi A; Oda Y; Nakada Y; Goto S Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):235-6. PubMed ID: 8582042 [TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers. Boisdron-Celle M; Menei P; Benoit JP J Pharm Pharmacol; 1995 Feb; 47(2):108-14. PubMed ID: 7602463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]